Skip to Content

How much does Luxturna cost?

Answers (1)

Official Answer by Drugs.com 7 Mar 2018

In December 2017 Luxturna (voretigene neparvovec-rzyl), a form of gene therapy, was FDA-approved to treat a rare group of inherited vision disorders known as biallelic RPE65-mediated inherited retinal disease (IRD). The cost of Luxturna, from Sparks Therapeutics, is $850,000 per a one-time treatment; however, the manufacturer states it is offering outcomes-based pricing and other innovative payment tools to lessen the cost of treatment to insurers and patients.

How is Luxturna given? - Luxturna is an adeno-associated viral (AAV) vector gene therapy tested in studies and given by subretinal injection to directly deliver a normal copy of the RPE65 gene directly into the eye. Biallelic RPE65-mediated inherited retinal disease can lead to blindness and occurs in roughly 1,000 to 2,000 people in the U.S.

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What eye condition is Oxervate used to treat?

Posted 8 days ago 1 answerFAQ by Drugs.com

What is the difference between Inveltys, Lotemax and Alrex?

Posted 8 days ago 1 answerFAQ by Drugs.com

What type of drug is Takhzyro?

Posted 8 days ago 1 answerFAQ by Drugs.com

What type of drug is Xerava?

Posted 8 days ago 1 answerFAQ by Drugs.com